0.008331 0.004810 0.000000 0.000000 0.009620 0.000000 0.000000 0.000000 0.010552 0.000000 0.000000 0.000000 Joint Center for Structural Genomics (JCSG) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 12 90.000 90.000 120.000 120.029 120.029 94.767 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 Se 196.106 n SELENOMETHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be published 0353 Crystal structure of hypothetical protein BT_3535 (NP_812447.1) from BACTERIODES THETAIOTAOMICRON VPI-5482 at 2.60 A resolution 10.2210/pdb3kny/pdb pdb_00003kny 100 1 Flat mirror (vertical focusing) CCD 2009-07-08 MARMOSAIC 325 mm CCD Single crystal Si(111) bent monochromator (horizontal focusing) MAD M x-ray 1 0.91162 1.0 0.97941 1.0 BL11-1 SSRL 0.91162,0.97941 SYNCHROTRON SSRL BEAMLINE BL11-1 24645.857 hypothetical protein BT_3535 1 man polymer no yes GACEQNEDWVVNEP(MSE)QSFEENPEYAPLNTIPDWVSEKVTPKEYELWRT(MSE)SSRYEINYSFLKKDISEKRKKEI YDCINNICERIEKGQINKYEGFLNIADEDGTTLSDSQYFGRIATRSPEGGAEYKTNGCTLYTHSLGPYIKAAVTYKKSDD DVTITSSSVYTGSPYLGNDPSFSGASSVSYDKDKKLIAASCSGTLSFKDGSRKVEVTVQKTGF(MSE)IP GACEQNEDWVVNEPMQSFEENPEYAPLNTIPDWVSEKVTPKEYELWRTMSSRYEINYSFLKKDISEKRKKEIYDCINNIC ERIEKGQINKYEGFLNIADEDGTTLSDSQYFGRIATRSPEGGAEYKTNGCTLYTHSLGPYIKAAVTYKKSDDDVTITSSS VYTGSPYLGNDPSFSGASSVSYDKDKKLIAASCSGTLSFKDGSRKVEVTVQKTGFMIP A 393001 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n sample BT_3535 226186 Bacteroides thetaiotaomicron VPI-5482 562 Escherichia Coli HK100 Plasmid SpeedET 1 4.00 69.23 VAPOR DIFFUSION, SITTING DROP 6.93 40.9000% 2-methyl-2,4-pentanediol, 0.1M HEPES pH 6.93, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K 277 Joint Center for Structural Genomics JCSG PSI, Protein Structure Initiative pdbx_struct_assembly_auth_evidence software software struct_conn database_2 struct_ref_seq_dif repository Initial release Advisory Version format compliance Author supporting evidence Refinement description Data collection Derived calculations Refinement description Database references 1 0 2009-12-01 1 1 2011-07-13 1 2 2017-10-25 1 3 2019-07-17 1 4 2023-02-01 _software.classification _software.name _software.classification _software.contact_author _software.contact_author_email _software.language _software.location _software.name _software.type _software.version _struct_conn.pdbx_leaving_atom_flag _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details Y RCSB Y RCSB 2009-11-12 REL REL THE CONSTRUCT (RESIDUES 18-234) WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. n 1 0 A n 2 18 A n 3 19 A n 4 20 A n 5 21 A ASN 22 n 6 ASN 22 A GLU 23 n 7 GLU 23 A ASP 24 n 8 ASP 24 A TRP 25 n 9 TRP 25 A VAL 26 n 10 VAL 26 A VAL 27 n 11 VAL 27 A ASN 28 n 12 ASN 28 A GLU 29 n 13 GLU 29 A PRO 30 n 14 PRO 30 A MSE 31 n 15 MSE 31 A GLN 32 n 16 GLN 32 A SER 33 n 17 SER 33 A PHE 34 n 18 PHE 34 A GLU 35 n 19 GLU 35 A GLU 36 n 20 GLU 36 A ASN 37 n 21 ASN 37 A PRO 38 n 22 PRO 38 A GLU 39 n 23 GLU 39 A TYR 40 n 24 TYR 40 A ALA 41 n 25 ALA 41 A PRO 42 n 26 PRO 42 A LEU 43 n 27 LEU 43 A ASN 44 n 28 ASN 44 A THR 45 n 29 THR 45 A ILE 46 n 30 ILE 46 A PRO 47 n 31 PRO 47 A ASP 48 n 32 ASP 48 A TRP 49 n 33 TRP 49 A VAL 50 n 34 VAL 50 A SER 51 n 35 SER 51 A GLU 52 n 36 GLU 52 A LYS 53 n 37 LYS 53 A VAL 54 n 38 VAL 54 A THR 55 n 39 THR 55 A PRO 56 n 40 PRO 56 A LYS 57 n 41 LYS 57 A GLU 58 n 42 GLU 58 A TYR 59 n 43 TYR 59 A GLU 60 n 44 GLU 60 A LEU 61 n 45 LEU 61 A TRP 62 n 46 TRP 62 A ARG 63 n 47 ARG 63 A THR 64 n 48 THR 64 A MSE 65 n 49 MSE 65 A SER 66 n 50 SER 66 A SER 67 n 51 SER 67 A ARG 68 n 52 ARG 68 A TYR 69 n 53 TYR 69 A GLU 70 n 54 GLU 70 A ILE 71 n 55 ILE 71 A ASN 72 n 56 ASN 72 A TYR 73 n 57 TYR 73 A SER 74 n 58 SER 74 A PHE 75 n 59 PHE 75 A LEU 76 n 60 LEU 76 A LYS 77 n 61 LYS 77 A LYS 78 n 62 LYS 78 A ASP 79 n 63 ASP 79 A ILE 80 n 64 ILE 80 A SER 81 n 65 SER 81 A GLU 82 n 66 GLU 82 A LYS 83 n 67 LYS 83 A ARG 84 n 68 ARG 84 A LYS 85 n 69 LYS 85 A LYS 86 n 70 LYS 86 A GLU 87 n 71 GLU 87 A ILE 88 n 72 ILE 88 A TYR 89 n 73 TYR 89 A ASP 90 n 74 ASP 90 A CYS 91 n 75 CYS 91 A ILE 92 n 76 ILE 92 A ASN 93 n 77 ASN 93 A ASN 94 n 78 ASN 94 A ILE 95 n 79 ILE 95 A CYS 96 n 80 CYS 96 A GLU 97 n 81 GLU 97 A ARG 98 n 82 ARG 98 A ILE 99 n 83 ILE 99 A GLU 100 n 84 GLU 100 A LYS 101 n 85 LYS 101 A GLY 102 n 86 GLY 102 A GLN 103 n 87 GLN 103 A ILE 104 n 88 ILE 104 A ASN 105 n 89 ASN 105 A LYS 106 n 90 LYS 106 A TYR 107 n 91 TYR 107 A GLU 108 n 92 GLU 108 A GLY 109 n 93 GLY 109 A PHE 110 n 94 PHE 110 A LEU 111 n 95 LEU 111 A ASN 112 n 96 ASN 112 A ILE 113 n 97 ILE 113 A ALA 114 n 98 ALA 114 A ASP 115 n 99 ASP 115 A GLU 116 n 100 GLU 116 A ASP 117 n 101 ASP 117 A GLY 118 n 102 GLY 118 A THR 119 n 103 THR 119 A n 104 120 A n 105 121 A n 106 122 A n 107 123 A n 108 124 A n 109 125 A n 110 126 A n 111 127 A n 112 128 A n 113 129 A n 114 130 A n 115 131 A n 116 132 A n 117 133 A n 118 134 A n 119 135 A n 120 136 A n 121 137 A n 122 138 A ALA 139 n 123 ALA 139 A GLU 140 n 124 GLU 140 A TYR 141 n 125 TYR 141 A LYS 142 n 126 LYS 142 A THR 143 n 127 THR 143 A ASN 144 n 128 ASN 144 A GLY 145 n 129 GLY 145 A CYS 146 n 130 CYS 146 A THR 147 n 131 THR 147 A LEU 148 n 132 LEU 148 A TYR 149 n 133 TYR 149 A THR 150 n 134 THR 150 A HIS 151 n 135 HIS 151 A SER 152 n 136 SER 152 A LEU 153 n 137 LEU 153 A GLY 154 n 138 GLY 154 A PRO 155 n 139 PRO 155 A TYR 156 n 140 TYR 156 A ILE 157 n 141 ILE 157 A LYS 158 n 142 LYS 158 A ALA 159 n 143 ALA 159 A ALA 160 n 144 ALA 160 A VAL 161 n 145 VAL 161 A THR 162 n 146 THR 162 A TYR 163 n 147 TYR 163 A LYS 164 n 148 LYS 164 A LYS 165 n 149 LYS 165 A SER 166 n 150 SER 166 A ASP 167 n 151 ASP 167 A ASP 168 n 152 ASP 168 A ASP 169 n 153 ASP 169 A VAL 170 n 154 VAL 170 A THR 171 n 155 THR 171 A ILE 172 n 156 ILE 172 A THR 173 n 157 THR 173 A SER 174 n 158 SER 174 A SER 175 n 159 SER 175 A SER 176 n 160 SER 176 A VAL 177 n 161 VAL 177 A TYR 178 n 162 TYR 178 A THR 179 n 163 THR 179 A GLY 180 n 164 GLY 180 A SER 181 n 165 SER 181 A PRO 182 n 166 PRO 182 A TYR 183 n 167 TYR 183 A LEU 184 n 168 LEU 184 A GLY 185 n 169 GLY 185 A ASN 186 n 170 ASN 186 A ASP 187 n 171 ASP 187 A PRO 188 n 172 PRO 188 A SER 189 n 173 SER 189 A PHE 190 n 174 PHE 190 A SER 191 n 175 SER 191 A GLY 192 n 176 GLY 192 A ALA 193 n 177 ALA 193 A SER 194 n 178 SER 194 A SER 195 n 179 SER 195 A VAL 196 n 180 VAL 196 A SER 197 n 181 SER 197 A TYR 198 n 182 TYR 198 A ASP 199 n 183 ASP 199 A LYS 200 n 184 LYS 200 A ASP 201 n 185 ASP 201 A LYS 202 n 186 LYS 202 A LYS 203 n 187 LYS 203 A LEU 204 n 188 LEU 204 A ILE 205 n 189 ILE 205 A ALA 206 n 190 ALA 206 A ALA 207 n 191 ALA 207 A SER 208 n 192 SER 208 A CYS 209 n 193 CYS 209 A SER 210 n 194 SER 210 A GLY 211 n 195 GLY 211 A THR 212 n 196 THR 212 A LEU 213 n 197 LEU 213 A SER 214 n 198 SER 214 A PHE 215 n 199 PHE 215 A LYS 216 n 200 LYS 216 A ASP 217 n 201 ASP 217 A GLY 218 n 202 GLY 218 A SER 219 n 203 SER 219 A ARG 220 n 204 ARG 220 A LYS 221 n 205 LYS 221 A VAL 222 n 206 VAL 222 A GLU 223 n 207 GLU 223 A VAL 224 n 208 VAL 224 A THR 225 n 209 THR 225 A VAL 226 n 210 VAL 226 A GLN 227 n 211 GLN 227 A LYS 228 n 212 LYS 228 A THR 229 n 213 THR 229 A GLY 230 n 214 GLY 230 A PHE 231 n 215 PHE 231 A MSE 232 n 216 MSE 232 A ILE 233 n 217 ILE 233 A PRO 234 n 218 PRO 234 A 2.1646 -0.0790 0.0565 2.1458 -0.5020 2.5958 0.0022 -0.3427 -0.4283 0.3511 -0.0696 0.0818 0.2689 0.0283 0.0674 0.1326 -0.0389 0.0216 0.0877 0.0683 0.0905 refined 87.2446 32.9840 -4.0255 X-RAY DIFFRACTION A 22 A 234 X-RAY DIFFRACTION 1 author_defined_assembly 1 monomeric software_defined_assembly PISA 2 dimeric gel filtration 1410 0 18790 A MSE 31 SELENOMETHIONINE A MSE 15 MET A MSE 65 SELENOMETHIONINE A MSE 49 MET A MSE 232 SELENOMETHIONINE A MSE 216 MET 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 -0.8660254038 0.0000000000 -0.8660254038 0.5000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 9_764 -x+2,-x+y+1,-z-1/3 crystal symmetry operation 180.0435000000 103.9481631908 -31.5890000000 A N VAL 26 A N VAL 10 A O THR 225 A O THR 209 A O ILE 233 A O ILE 217 A N ASN 112 A N ASN 96 A O GLY 109 A O GLY 93 A N GLU 70 A N GLU 54 A N VAL 26 A N VAL 10 A O THR 225 A O THR 209 A O VAL 224 A O VAL 208 A N LEU 213 A N LEU 197 A O LEU 204 A O LEU 188 A N ASP 199 A N ASP 183 A N CYS 146 A N CYS 130 A O ALA 159 A O ALA 143 A N LYS 158 A N LYS 142 A O TYR 178 A O TYR 162 1 A CG ASN 22 A CG ASN 6 1 Y 1 A OD1 ASN 22 A OD1 ASN 6 1 Y 1 A ND2 ASN 22 A ND2 ASN 6 1 Y 1 A CG GLU 23 A CG GLU 7 1 Y 1 A CD GLU 23 A CD GLU 7 1 Y 1 A OE1 GLU 23 A OE1 GLU 7 1 Y 1 A OE2 GLU 23 A OE2 GLU 7 1 Y 1 A CD GLU 35 A CD GLU 19 1 Y 1 A OE1 GLU 35 A OE1 GLU 19 1 Y 1 A OE2 GLU 35 A OE2 GLU 19 1 Y 1 A CG ASP 167 A CG ASP 151 1 Y 1 A OD1 ASP 167 A OD1 ASP 151 1 Y 1 A OD2 ASP 167 A OD2 ASP 151 1 Y 1 A CZ ARG 220 A CZ ARG 204 1 Y 1 A NH1 ARG 220 A NH1 ARG 204 1 Y 1 A NH2 ARG 220 A NH2 ARG 204 1 Y 1 A CD LYS 221 A CD LYS 205 1 Y 1 A CE LYS 221 A CE LYS 205 1 Y 1 A NZ LYS 221 A NZ LYS 205 1 Y 1 A GLY 0 A GLY 1 1 Y 1 A ALA 18 A ALA 2 1 Y 1 A CYS 19 A CYS 3 1 Y 1 A GLU 20 A GLU 4 1 Y 1 A GLN 21 A GLN 5 1 Y 1 A THR 120 A THR 104 1 Y 1 A LEU 121 A LEU 105 1 Y 1 A SER 122 A SER 106 1 Y 1 A ASP 123 A ASP 107 1 Y 1 A SER 124 A SER 108 1 Y 1 A GLN 125 A GLN 109 1 Y 1 A TYR 126 A TYR 110 1 Y 1 A PHE 127 A PHE 111 1 Y 1 A GLY 128 A GLY 112 1 Y 1 A ARG 129 A ARG 113 1 Y 1 A ILE 130 A ILE 114 1 Y 1 A ALA 131 A ALA 115 1 Y 1 A THR 132 A THR 116 1 Y 1 A ARG 133 A ARG 117 1 Y 1 A SER 134 A SER 118 1 Y 1 A PRO 135 A PRO 119 1 Y 1 A GLU 136 A GLU 120 1 Y 1 A GLY 137 A GLY 121 1 Y 1 A GLY 138 A GLY 122 1 Y 1 A A CB SG CYS CYS 146 146 -0.233 0.016 1.812 1.579 N 1 A A NE NE ARG ARG 220 220 2.11 1_555 10_664 1 A SER 51 -59.81 -8.22 1 A LYS 77 -89.64 36.66 1 A ILE 104 -106.23 79.44 1 A ASP 117 -39.23 121.22 1 A CYS 146 -171.94 127.29 1 A ASP 217 -112.37 70.25 86.95 39.252 10.55 1.280 0.640 0.000 1.280 0.000 -1.920 0.946 0.922 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 3. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 0.239 0.202 0.204 2.600 28.831 629 12878 4.900 99.870 1.00 0.50 18.125 0.171 RANDOM LIKELY RESIDUAL 1 THROUGHOUT 0.00 MAD 0.269 0.224 0.800 0.800 1.200 MAXIMUM LIKELIHOOD WITH PHASES MASK 2.600 28.831 0 1526 0 0 1526 0.015 0.022 1573 0.002 0.020 1068 1.536 1.959 2132 0.819 3.000 2620 5.773 5.000 194 33.512 25.294 68 16.351 15.000 274 11.566 15.000 4 0.084 0.200 231 0.006 0.021 1736 0.001 0.020 304 1.675 3.000 970 0.313 3.000 390 3.187 5.000 1575 5.109 8.000 603 7.184 11.000 556 0.407 0.361 2.667 45 894 939 20 99.790 2.60 28.831 3KNY 12900 0.124 0.124 1 16.700 10.500 99.900 0.011 2.60 2.67 0.7 10029 941 1.056 1 10.70 100.00 0.011 2.67 2.74 0.9 9701 902 0.822 1 10.80 100.00 0.011 2.74 2.82 1.1 9399 870 0.692 1 10.80 100.00 0.011 2.82 2.91 1.4 9369 866 0.564 1 10.80 100.00 0.011 2.91 3.00 1.8 9033 842 0.440 1 10.70 100.00 0.011 3.00 3.11 2.4 8566 790 0.326 1 10.80 100.00 0.011 3.11 3.22 3.0 8399 784 0.259 1 10.70 100.00 0.011 3.22 3.36 3.8 8120 763 0.199 1 10.60 100.00 0.011 3.36 3.51 4.7 7630 715 0.154 1 10.70 100.00 0.011 3.51 3.68 5.8 7463 700 0.125 1 10.70 100.00 0.011 3.68 3.88 6.7 7087 672 0.109 1 10.50 100.00 0.011 3.88 4.11 7.7 6580 621 0.094 1 10.60 100.00 0.011 4.11 4.39 9.1 6332 604 0.074 1 10.50 100.00 0.011 4.39 4.75 10.8 5902 567 0.063 1 10.40 100.00 0.011 4.75 5.20 10.8 5322 513 0.061 1 10.40 100.00 0.011 5.20 5.81 9.6 4904 478 0.070 1 10.30 100.00 0.011 5.81 6.71 9.2 4280 429 0.073 1 10.00 100.00 0.011 6.71 8.22 10.1 3576 364 0.063 1 9.80 100.00 0.011 8.22 11.63 10.9 2841 304 0.053 1 9.30 100.00 0.011 11.63 28.83 12.4 1398 175 0.048 1 8.00 93.80 refinement Garib N. Murshudov garib@ysbl.york.ac.uk Fortran_77 http://www.ccp4.ac.uk/dist/html/refmac5.html REFMAC program 5.5.0053 refinement P.D. Adams PDAdams@lbl.gov C++ http://www.phenix-online.org/ PHENIX package phasing George M. Sheldrick gsheldr@shelx.uni-ac.gwdg.de Fortran_77 http://shelx.uni-ac.gwdg.de/SHELX/ SHELX package model building D.C. & J.S. Richardson lab molprobity@kinemage.biochem.duke.edu http://kinemage.biochem.duke.edu/molprobity/ MolProbity package 3beta29 data scaling Phil R. Evans pre@mrc-lmb.cam.ac.uk 5/04/2004 Fortran_77 http://www.ccp4.ac.uk/dist/html/scala.html SCALA other 3.2.5 data extraction PDB help@deposit.rcsb.org June 11, 2008 C++ http://sw-tools.pdb.org/apps/PDB_EXTRACT/ PDB_EXTRACT package 3.006 data reduction MOSFLM phasing SHELXD phasing autoSHARP Crystal structure of a two domain protein with unknown function (bt_3535) from bacteroides thetaiotaomicron vpi-5482 at 2.60 A resolution 1 N N ANALYTICAL SIZE-EXCLUSION CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT OF A MONOMER AS THE SIGNIFICANT OLIGOMERIC FORM IN SOLUTION. A SER 33 A SER 17 HELX_P A ASN 37 A ASN 21 5 1 5 A PRO 47 A PRO 31 HELX_P A LYS 53 A LYS 37 5 2 7 A THR 55 A THR 39 HELX_P A SER 66 A SER 50 1 3 12 A TYR 73 A TYR 57 HELX_P A LYS 77 A LYS 61 5 4 5 A SER 81 A SER 65 HELX_P A LYS 101 A LYS 85 1 5 21 covale 1.334 both A MSE 31 A C MSE 15 1_555 A GLN 32 A N GLN 16 1_555 covale 1.335 both A MSE 65 A C MSE 49 1_555 A SER 66 A N SER 50 1_555 covale 1.336 both A MSE 232 A C MSE 216 1_555 A ILE 233 A N ILE 217 1_555 UNKNOWN FUNCTION Structural genomics, Joint Center for Structural Genomics, JCSG, Protein Structure Initiative, PSI-2, unknown function Q8A1X3_BACTN UNP 1 18 Q8A1X3 ACEQNEDWVVNEPMQSFEENPEYAPLNTIPDWVSEKVTPKEYELWRTMSSRYEINYSFLKKDISEKRKKEIYDCINNICE RIEKGQINKYEGFLNIADEDGTTLSDSQYFGRIATRSPEGGAEYKTNGCTLYTHSLGPYIKAAVTYKKSDDDVTITSSSV YTGSPYLGNDPSFSGASSVSYDKDKKLIAASCSGTLSFKDGSRKVEVTVQKTGFMIP 18 234 3KNY 18 234 Q8A1X3 A 1 2 218 1 expression tag GLY 0 3KNY A Q8A1X3 UNP 1 4 4 3 parallel parallel parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel A GLU 23 A GLU 7 A VAL 26 A VAL 10 A ARG 220 A ARG 204 A ILE 233 A ILE 217 A GLY 109 A GLY 93 A ILE 113 A ILE 97 A TYR 69 A TYR 53 A ILE 71 A ILE 55 A GLU 23 A GLU 7 A VAL 26 A VAL 10 A ARG 220 A ARG 204 A ILE 233 A ILE 217 A LEU 204 A LEU 188 A ASP 217 A ASP 201 A SER 189 A SER 173 A ASP 199 A ASP 183 A GLU 140 A GLU 124 A THR 150 A THR 134 A TYR 156 A TYR 140 A LYS 165 A LYS 149 A VAL 170 A VAL 154 A GLY 180 A GLY 164 181 P 64 2 2